CHICAGO, Feb. 22, 2010 -- SAVE THE DATE for the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (ICAD 2010), July 10-15, 2010, at the Hawai'i Convention Center, Honolulu, Hawaii.
Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO)
ICAD 2010 is the premier forum on Alzheimer's disease and dementia research. Learn about the groundbreaking new theories, methods and results that will be revealed for the first time. The conference will bring together more than 5,000 leading experts and researchers from around the world and feature more then 2,000 scientific presentations. Presentations will cover the spectrum of Alzheimer research, including causes, risk factors, detection and diagnosis, treatment, and prevention.
Advertisement
We anticipate news regarding (subject to change):
News media registration is now open at http://www.alz.org/icad/media_reg.asp.
Press registration for ICAD 2010 is available only to credentialed reporters, writers or editors from recognized external print, broadcast, syndicated or online news organizations. If you have questions regarding press registration for ICAD 2010, please contact us at (312) 335-4078 or [email protected].
In the coming months, we will provide:
All materials to be presented at the ICAD 2010 are embargoed for publication and broadcast until the date and time of presentation at the conference, unless the Alzheimer's Association provides written notice of change of date and/or time in advance.
Visit our ICAD website regularly for information and updates.
http://www.alz.org/icad/
http://www.alz.org/icad/icad_pressroom.asp
CONTACT: Niles Frantz of the Alzheimer's Association, Public Relations, +1-312-335-5777, [email protected] or the Alzheimer's Association media line, +1-312-335-4078, [email protected]
/PRNewswire-USNewswire -- Feb. 22/-- The latest in drug trials at all stages of development. -- Emerging roles for imaging and fluid biomarkers in the diagnosis of Alzheimer's. -- A national effort to accelerate the development of new treatments and preventions. -- A new tool for encouraging more people to volunteer for Alzheimer's clinical studies. -- How the most promising therapies in the pipeline work in the brain. -- New options for identifying people earlier in the course of Alzheimer's, even before symptoms become evident. -- Findings from we're learning by studying the adult children of people with Alzheimer's. -- How Alzheimer's/dementia in the "oldest-old" is different than that in younger people. -- New ideas about actions in midlife that may reduce risk of Alzheimer's in later life. -- Insights into the relationships between Alzheimer's and sleep disturbances, diet, frailty, obesity, diabetes, epilepsy, friendship, social networks, and more.
SOURCE Alzheimer's Association
